Cargando…
Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration
Cisplatin is a highly emetogenic cancer chemotherapy agent, which is often used to induce nausea and emesis in animal models. The cytotoxic properties of cisplatin also cause adverse events that negatively impact on animal welfare preventing repeated administration of cisplatin. In this study, we as...
Autores principales: | Kenward, Hannah, Pelligand, Ludovic, Elliott, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353862/ https://www.ncbi.nlm.nih.gov/pubmed/24792501 http://dx.doi.org/10.1007/s00221-014-3961-6 |
Ejemplares similares
-
Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study
por: Kenward, Hannah, et al.
Publicado: (2017) -
The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome
por: Foth, S., et al.
Publicado: (2021) -
Ondansetron in dogs with nausea associated with vestibular disease: A double‐blinded, randomized placebo‐controlled crossover study
por: Henze, Lea, et al.
Publicado: (2022) -
Population Pharmacokinetics and Pharmacodynamics Modeling of Torasemide and Furosemide After Oral Repeated Administration in Healthy Dogs
por: Pelligand, Ludovic, et al.
Publicado: (2020) -
Evaluation of nausea and vomiting in pregnancy using the Pregnancy-Unique Quantification of Emesis and Nausea scale in Korea
por: Choi, Hyun Joung, et al.
Publicado: (2018)